MET and cancer: The hepatocyte growth factor/c-Met (HGF/c-Met) pathway is a key mediator in the mesenchymal-epithelial transition, a process required for the invasion of blood or lymph vessels by cancer cells as a preliminary step to migrate cancer cells to distant organs [54].